Corporate brand
UnclaimedGV is Alphabet's venture capital investment arm, backing technology, healthcare, life-science, and artificial-intelligence companies from seed through growth stages.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
GV, legally identified as GV Management Company, L.L.C., is a venture capital investment organization owned by Alphabet Inc. It was established in 2009 as Google Ventures with an initial capital commitment of $100 million and was founded and initially led by Bill Maris. Although it originated within Google, the firm has operated with an independent investment mandate from Google's core search and advertising business and, following Google's corporate reorganization, from Alphabet's operating divisions. The organization adopted the name GV in December 2015. GV invests across a broad technology and innovation landscape rather than concentrating on a single consumer category. Its areas of interest have included internet businesses, enterprise and consumer software, hardware, transportation, cybersecurity, agriculture, artificial intelligence, healthcare, biotechnology, and other life-science fields. Companies associated with its investment portfolio include Uber, Nest, Slack, Stripe, and Flatiron Health. The portfolio illustrates GV's role as a financial investor in companies at different stages of development, from emerging startups to more established private technology businesses. The firm began with a seed- and venture-capital orientation. Its announced annual capital commitment increased to $300 million in 2012, and the organization later reported approximately $2 billion under management. In 2014, GV announced a $125 million commitment for promising European startups, with its European investing activities led by Tom Hulme from that period. The European initiative expanded the firm's geographic reach and complemented its United States investment activity. GV's investment model includes more than providing capital. The firm developed a structured five-day Design Sprint process in 2013 to help startup teams define problems, prototype solutions, and test ideas quickly. The process draws on agile development and design-thinking principles. GV has also provided portfolio companies with operational support in areas such as design, product management, marketing, engineering, and recruiting. These capabilities position the firm as an investment partner with hands-on expertise rather than solely as a passive source of funding. From around 2016, GV became less focused on early seed investing and shifted more attention toward mature companies. At the same time, healthcare and life sciences became increasingly important. The firm helped create Calico, a biotechnology company, and invested in businesses including Foundation Medicine, Genomics Medicine Ireland, Editas Medicine, and Flatiron Health. This healthcare emphasis gave GV exposure to drug discovery, diagnostics, genomics, medical data, and technology-enabled clinical services. GV has also emphasized diversity and artificial intelligence in its later development. In 2020, Terri Burns was promoted from principal to partner, becoming the firm's first Black female partner. Since 2023, the firm has pursued a stronger focus on AI-native startups under the leadership of Michael McBride, who joined from GitLab. Investments associated with this direction include Vercel, Lightmatter, Harvey, OpenEvidence, Synthesia, and Attio. GV Europe has reported that approximately 80 percent of its new investments were in AI or AI-native companies as of 2026, alongside more than $1 billion invested in European startups. In 2026, GV also participated as an existing investor in Stipple Bio's oversubscribed $100 million Series A financing. As an Alphabet-owned venture firm, GV gives Alphabet indirect exposure to private-market technology and life-science companies while maintaining a distinct brand and investment operation.
History
GV began on March 31, 2009, when Google created Google Ventures as a dedicated venture capital investment arm. Bill Maris founded the group and became its first chief executive. The initial capital commitment was $100 million, giving Google a vehicle for investing in startups without folding those activities into its core search, advertising, and internet-product operations. The organization expanded its financial capacity in 2012, when its annual commitment was reported to have risen to $300 million. Its assets under management were later described as approximately $2 billion. GV invested across internet services, software, hardware, transportation, cybersecurity, agriculture, healthcare, biotechnology, and other technology-intensive fields. Its portfolio came to include companies such as Uber, Nest, Slack, Stripe, and Flatiron Health, demonstrating a willingness to support both consumer-facing technology and specialized enterprise or healthcare businesses. International expansion became more visible in 2014. GV announced $125 million for investment in European startups, and Tom Hulme led the firm's European operations from that year. The European effort established a more explicit regional presence while retaining the firm's broader international investment mandate. In December 2015, Google Ventures changed its name to GV and introduced a new logo. The rebranding distinguished the venture organization from Google's operating businesses. GV continued to be affiliated with Google and, after Google's restructuring under Alphabet, became part of the wider Alphabet corporate structure. It operated independently from Google's search and advertising division, allowing its investment decisions to be made through a venture-capital framework rather than as extensions of Google's product roadmap. The firm's investment style also evolved. By 2016, GV was described as less active at the seed stage and more focused on mature companies. Healthcare and life sciences became an important area of activity. GV helped create Calico and invested in Foundation Medicine, Genomics Medicine Ireland, Editas Medicine, and Flatiron Health. These investments extended the firm's interests into biotechnology, genomics, diagnostics, and healthcare software. GV developed non-financial support for portfolio companies as part of its platform. In 2013, it created the Design Sprint, an intensive five-day process intended to help startup teams solve product and business problems rapidly. The approach combines elements of agile development and design thinking. GV also made partners and specialists available to assist with product management, design, marketing, engineering, and recruitment. This operating model made the firm's value proposition broader than capital alone. Leadership and thematic priorities continued to develop in the 2020s. In 2020, Terri Burns became the firm's first Black female partner after being promoted from principal. From 2023, GV's AI activity was associated with Michael McBride, who joined from GitLab. The firm invested in AI-native or AI-enabled companies including Vercel, Lightmatter, Harvey, OpenEvidence, Synthesia, and Attio. GV Europe later reported that roughly 80 percent of its new investments were in AI or AI-native companies as of 2026, while its cumulative investment in European startups exceeded $1 billion. In 2026, GV participated in Stipple Bio's $100 million Series A financing, extending its healthcare and precision-oncology activity. GV therefore developed from a Google-branded venture fund into a diversified Alphabet-backed investment platform with particular visibility in technology, healthcare, and artificial intelligence.
- 2026
European AI activity and Stipple Bio financing
[1]GV Europe reports that approximately 80 percent of new investments are in AI or AI-native companies, while GV participates in Stipple Bio's $100 million Series A financing.
- 2023
AI-native investing becomes a stronger focus
[1]GV's AI investment activity becomes associated with Michael McBride and a portfolio of AI-native or AI-enabled companies.
- 2020
Terri Burns becomes a partner
[1]Terri Burns is promoted from principal to partner and becomes GV's first Black female partner.
- 2016
Investment emphasis moves toward later-stage companies
[1]GV becomes less active in seed investing and increases attention to more mature businesses and healthcare startups.
- 2015
The organization adopts the GV name
[1]Google Ventures is renamed GV and receives a new logo in December.
- 2014
European investment program is announced
[1]GV announces $125 million for promising European startups, with Tom Hulme leading European operations.
- 2013
Design Sprint is developed
[1]GV develops a five-day Design Sprint framework to help startup teams test ideas and address product problems quickly.
- 2012
Annual capital commitment rises
[1]The group's annual investment commitment is reported to increase to $300 million, reflecting the expansion of its venture activity.
- 2009
Google Ventures is founded
[1]Google establishes the venture capital group on March 31 with a reported initial capital commitment of $100 million. Bill Maris becomes founder and first chief executive.
Products and positioning
An Alphabet-backed, sector-diverse venture capital firm combining startup financing with hands-on operational support and increasing emphasis on healthcare, life sciences, and AI-native companies.
Investment service · 2009
Venture capital financing
GV provides seed, venture, and growth-stage capital to private companies. Its investment scope has included internet businesses, software, hardware, transportation, cybersecurity, agriculture, healthcare, biotechnology, and artificial intelligence. The firm has supported companies at different levels of maturity and has increasingly emphasized later-stage businesses compared with its earlier seed-investment orientation.
Sector investment portfolio
Healthcare and life-science investments
GV's healthcare and life-science activity includes the creation of Calico and investments in Foundation Medicine, Genomics Medicine Ireland, Editas Medicine, and Flatiron Health. The portfolio spans biotechnology, genomics, diagnostics, precision medicine, and healthcare technology.
Sector investment portfolio · 2023
AI-native startup investments
Since 2023, GV has placed greater emphasis on companies built around artificial intelligence. Associated investments include Vercel, Lightmatter, Harvey, OpenEvidence, Synthesia, and Attio. This activity covers infrastructure, enterprise applications, professional software, and other AI-enabled products.
Startup support methodology · 2013
Design Sprint
The Design Sprint is an intensive five-day process developed by GV to help startup teams define a problem, explore possible solutions, build a prototype, and obtain rapid feedback. It draws on agile development and design-thinking practices and forms part of GV's operational support for portfolio companies.
Brand decisions
2023
Increase emphasis on AI-native companiesStrategyBackground
Artificial intelligence became a major venture-investment theme across the technology sector, and GV identified AI as a stronger area of focus.
Action taken
Under an investment focus associated with Michael McBride, GV expanded activity in AI-native and AI-enabled startups.
Aftermath
The firm became associated with investments in companies including Vercel, Lightmatter, Harvey, OpenEvidence, Synthesia, and Attio; GV Europe later reported that most new investments were AI-related.
2016
Shift toward mature companies and healthcareStrategyBackground
GV's initial identity was strongly associated with startup and seed investing, but the firm had developed a broader portfolio and greater capacity for later-stage investments.
Action taken
GV became less active as a seed investor and directed more attention toward mature companies and healthcare startups.
Aftermath
Healthcare and life sciences became a more prominent part of the portfolio alongside technology investing.
2015
Rebrand Google Ventures as GVStrategyBackground
The venture group operated within the broader Google and later Alphabet corporate environment while maintaining a distinct investment role.
Action taken
The organization changed its name to GV and introduced a new logo in December.
Aftermath
The new identity separated the investment firm's brand from Google's operating businesses while preserving its affiliation with Alphabet.
Recent events
Reported
Armadin raises $255.5M Series B at over $2.5B valuation[2]
Armadin, the agent-swarm security startup founded by Kevin Mandia, announced on Thursday (2026-10-01) that it raised $255.5 million in a Series B round at a valuation of more than $2.5 billion. The round was led by Andreessen Horowitz and Accel, with Bain Capital Ventures, Redpoint, 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures joining in.
Weekdays and relative dates follow the original report; their exact calendar dates have not been verified.
Reported
Censys completes $35 million Series B funding round[3]
Censys announced that it completed a $35 million Series B funding round led by Intel Capital, with previous investors including Google Ventures, Decibel and Greylock Partners also participating.
Reported
Found raises $100 million in Series B funding[4]
Found raised $100 million in Series B funding led by WestCap, with participation from other new and existing investors.
Reported
Agtonomy announces $4 million seed round[5]
Agtonomy announced a $4 million seed round from Grit Ventures, GV and Village Global.
Reported
Xilis closes $70 million Series A financing[6]
Xilis announced the close of a $70 million Series A financing led by Mubadala Capital, with new and existing investors participating.
- Unconfirmed
Neo4j raises $325 million in Series F financing[7]
Neo4j raised $325 million in a Series F financing round. The company said the funding would support development of multi-cloud services and graph data science and help expand its market reach.
Reported
Overture Life raises $15 million in Series B funding[8]
Overture Life announced the closing of a $15 million Series B financing led by Octopus Ventures, with participation from GV and existing investors. The company said it would use the proceeds to increase operations in Europe and the US and begin commercializing its first products.
Reported
OneNav completes $21 million Series B funding[9]
OneNav announced that it had completed a $21 million Series B funding round led by GV's Karim Faris, with other investors including Norwest's Matthew Howard and GSR Ventures.
Reported
Altana AI closes $15 million Series A funding round[10]
Altana AI secured $15 million in Series A funding led by GV, with Floating Point, Ridgeline Partners, Amadeus Capital Partners and Schematic Ventures also participating. The round closed in May 2021.
Reported
Tend announces $125 million Series C funding[11]
Tend announced it had raised $125 million in Series C funding, led by Addition, with participation from existing investors GV, Juxtapose, Redpoint and Zigg Capital.
Sources19 sources
- 1GV (company)en.wikipedia.org
- 2Armadin以逾25亿美元估值完成2.555亿美元B轮融资techcrunch.com
- 3Censys完成3500万美元B轮融资prnewswire.com
- 4Found完成1亿美元B轮融资prweb.com
- 5Agtonomy宣布获得400万美元种子轮融资prnewswire.com
- 6Xilis完成7000万美元A轮融资finanznachrichten.de
- 7Neo4j完成3.25亿美元F轮融资crn.com
- 8Overture Life 完成 1,500 万美元 B 轮融资prweb.com
- 9OneNav完成2100万美元B轮融资finance.sina.com.cn
- 10Altana AI完成1500万美元A轮融资prnewswire.com
- 11Tend宣布完成1.25亿美元C轮融资prnewswire.com
- 12SpyBiotech完成3250万美元A轮融资finanznachrichten.de
- 13Multiverse完成4400万美元B轮融资techcrunch.com
- 14Uber领投Lime的1.7亿美元融资bikebiz.com
- 15Ventus Therapeutics宣布6000万美元A轮融资financialpost.com
- 16Digits 宣布获得 2,200 万美元 B 轮融资finance.yahoo.com
- 17Digits宣布获得2200万美元B轮融资techcrunch.com
- 18Censys raises $35 million to accelerate product development and sales operations - Help Net Securityhelpnetsecurity.com
- 19Ventus Launches with $60 Million to Study Diseases of the Innate Immune Systembiospace.com
Cite this profile: Cite the canonical profile. /brand-wiki/gv · Editorial policy · How profiles are compiled